Targeting the transcriptional kinases CDK12 and CDK13 in breast and ovarian cancer

被引：2
|
作者：
Bradley, Michael
Marineau, Jason
Choi, Yoon
Hamman, Kristin
Malojcic, Goran
Orlando, David
Ren, Yixuan
Ke, Nan
Hu, Shanhu
Olson, Eric
Fritz, Christian
Roberts, Christopher
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1143
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1143
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Therapeutic potential of dual CDK12 and 13 inhibition in colorectal cancer
    Altunel, Erdem
    Zokaasadi, Mohammad
    Somarelli, Jason A.
    McCall, Shannon J.
    Gultawatvichai, Patan
    Whalen, Giles Francis
    Pitarresi, Jason
    Hsu, David S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [32] MYC up-regulation confers vulnerability to dual inhibition of CDK12 and CDK13 in high-risk Group 3 medulloblastoma
    Consuelo Pitolli
    Alberto Marini
    Marika Guerra
    Marco Pieraccioli
    Veronica Marabitti
    Fernando Palluzzi
    Luciano Giacò
    Gianpiero Tamburrini
    Francesco Cecconi
    Francesca Nazio
    Claudio Sette
    Vittoria Pagliarini
    Journal of Experimental & Clinical Cancer Research, 42
  • [33] The promise and current status of CDK12/13 inhibition for the treatment of cancer
    Tadesse, Solomon
    Duckett, Derek R.
    Monastyrskyi, Andrii
    FUTURE MEDICINAL CHEMISTRY, 2021, 13 (02) : 117 - 141
  • [34] Research progress of anticancer drugs targeting CDK12
    Yan, Zhijia
    Du, Yongli
    Zhang, Haibin
    Zheng, Yong
    Lv, Huiting
    Dong, Ning
    He, Fang
    RSC MEDICINAL CHEMISTRY, 2023, 14 (09): : 1629 - 1644
  • [35] Targeting CDK12 to treat DM1
    Sarah Crunkhorn
    Nature Reviews Drug Discovery, 2020, 19 (6) : 388 - 388
  • [36] AR-A014418 regulates intronic polyadenylation and transcription of PD-L1 through inhibiting CDK12 and CDK13 in tumor cells
    Zhang, Ganggang
    Lan, Bin
    Zhang, Xin
    Lin, Mengyao
    Liu, Yi
    Chen, Junsong
    Guo, Fang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (05)
  • [37] A deep learning approach to discover cyclin-dependent kinases 12 (CDK12) inhibitors in breast cancer.
    Wen, Tingyu
    Li, Lixi
    Li, Yiqun
    Wang, Jun
    Gao, Peng
    Xie, Guotong
    Ma, Fei
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [38] CDK12 Changes Telling in Prostate Cancer
    Caruso, Catherine
    CANCER DISCOVERY, 2018, 8 (09) : 1055 - 1056
  • [39] Characterisation of pharmacological phenotypes of CDK12/ 13 inhibition
    Jacob, K.
    Thomann, A.
    Weber, C.
    Gudennann, T.
    Peters, A.
    Zierfer, S.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 : S70 - S70
  • [40] Targeting cdk12/13 re-sensitizes trastuzumab resistant her2+breast cancers
    Vena, Francesca
    Aceti, Max
    Bayle, Simon
    Quereda, Victor
    Monastyrskyi, Andrii
    Roush, William
    Duckett, Derek
    CANCER RESEARCH, 2019, 79 (13)
12345